Trial Profile
Phase I/II study investigating increasing doses of bevacizumab in patients with malignant effusion
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 20 May 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Cancer; Malignant pleural effusion
- Focus Therapeutic Use
- 20 May 2015 New trial record